SNN Stock Analysis: Buy, Sell, or Hold?
SNN - Smith & Nephew plc
$30.25
1.52 (5.29%)
▲
5d:
+0.1%
30d:
+3.03%
90d:
-5.73%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
30d
Get Alerted When SNN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$50.01
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$31.05
2.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNN is currently trading at $30.25, which is considered fair relative to its 30-day fair value range of $29.51 to $30.70. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.0) compared to its historical average (16.2). Remarkably, the market is currently pricing in an annual earnings decline of 4.7% over the next few years. This pessimistic expectation contrasts with the company's recent 70.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SNN is in a strong downtrend. The price is approaching resistance at $30.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: SNN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $34.99 (+15.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNN is in a strong downtrend. The price is approaching resistance at $30.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: SNN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $34.99 (+15.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$29.51 -
$30.70
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading below Wall St target ($34.99)
Trading Range Analysis
30-Day Trading Range
$29.51 -
$30.70
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$28.56
Resistance Level
$30.64
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.02
Wall Street Target
$34.99
(+15.7%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
70.4%
Profit Margin
10.1%
Valuation Discount vs History
-4.7% cheaper
PE vs Historical
14.0 vs 16.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.7%
(market-implied from PE analysis)
1-Year Target
$28.83
(-5%)
2-Year Target
$27.47
(-9%)
3-Year Target
$26.18
(-13%)
3-Yr Target (if PE normalizes)
(PE: 14→16)
$30.26
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.9%)
$64.12
(+112%)
Base:
(SPY PE: 14.0, Growth: 10.9%)
$41.26
(+36%)
Bear:
(PE: 11.9, Growth: 10.9%)
$35.07
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 20.09 | Current EPS (TTM): $1.43
Bull Case
$47.69
(+58%)
Analyst growth 50.9%, PE expands to 22.1
Base Case
$43.36
(+43%)
Market implied 50.9%, PE stable at 20.1
Bear Case
$19.54
(-35%)
Severe decline -20.0%, PE contracts to 17.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.0 to 16.2
Stabilization Target:
$34.96
(+15.6%)
PE Expansion Potential:
+15.6%
Share & Embed Analysis
Last updated: July 03, 2026 10:12 PM ET
Data refreshes hourly during market hours. Next update: 11:12 PM
Data refreshes hourly during market hours. Next update: 11:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
